ORGO
Price
$4.79
Change
-$0.22 (-4.40%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
606.38M
57 days until earnings call
SHIEF
Price
$0.10
Change
-$0.01 (-9.09%)
Updated
Aug 28 closing price
Capitalization
109.05M
Interact to see
Advertisement

ORGO vs SHIEF

Header iconORGO vs SHIEF Comparison
Open Charts ORGO vs SHIEFBanner chart's image
Organogenesis Holdings
Price$4.79
Change-$0.22 (-4.40%)
Volume$3.84K
Capitalization606.38M
Shield Therapeutics
Price$0.10
Change-$0.01 (-9.09%)
Volume$10.01K
Capitalization109.05M
ORGO vs SHIEF Comparison Chart in %
Loading...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORGO vs. SHIEF commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORGO is a Hold and SHIEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (ORGO: $5.00 vs. SHIEF: $0.10)
Brand notoriety: ORGO and SHIEF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ORGO: 50% vs. SHIEF: 103%
Market capitalization -- ORGO: $606.38M vs. SHIEF: $109.05M
ORGO [@Pharmaceuticals: Generic] is valued at $606.38M. SHIEF’s [@Pharmaceuticals: Generic] market capitalization is $109.05M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.25B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORGO’s FA Score shows that 1 FA rating(s) are green whileSHIEF’s FA Score has 0 green FA rating(s).

  • ORGO’s FA Score: 1 green, 4 red.
  • SHIEF’s FA Score: 0 green, 5 red.
According to our system of comparison, ORGO is a better buy in the long-term than SHIEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORGO’s TA Score shows that 5 TA indicator(s) are bullish while SHIEF’s TA Score has 3 bullish TA indicator(s).

  • ORGO’s TA Score: 5 bullish, 3 bearish.
  • SHIEF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than SHIEF.

Price Growth

ORGO (@Pharmaceuticals: Generic) experienced а -2.91% price change this week, while SHIEF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.30%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +86.94%.

Reported Earning Dates

ORGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.30% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORGO($606M) has a higher market cap than SHIEF($109M). SHIEF YTD gains are higher at: 203.328 vs. ORGO (56.250). ORGO has higher annual earnings (EBITDA): 3.19M vs. SHIEF (-12.92M). ORGO has more cash in the bank: 73.1M vs. SHIEF (10.8M). SHIEF has less debt than ORGO: SHIEF (27M) vs ORGO (40.8M). ORGO has higher revenues than SHIEF: ORGO (429M) vs SHIEF (41.5M).
ORGOSHIEFORGO / SHIEF
Capitalization606M109M556%
EBITDA3.19M-12.92M-25%
Gain YTD56.250203.32828%
P/E Ratio63.75N/A-
Revenue429M41.5M1,034%
Total Cash73.1M10.8M677%
Total Debt40.8M27M151%
FUNDAMENTALS RATINGS
ORGO vs SHIEF: Fundamental Ratings
ORGO
SHIEF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
3934
P/E GROWTH RATING
1..100
1194
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (75) in the Financial Conglomerates industry is in the same range as SHIEF (89) in the null industry. This means that ORGO’s stock grew similarly to SHIEF’s over the last 12 months.

ORGO's Profit vs Risk Rating (94) in the Financial Conglomerates industry is in the same range as SHIEF (100) in the null industry. This means that ORGO’s stock grew similarly to SHIEF’s over the last 12 months.

ORGO's SMR Rating (95) in the Financial Conglomerates industry is in the same range as SHIEF (98) in the null industry. This means that ORGO’s stock grew similarly to SHIEF’s over the last 12 months.

SHIEF's Price Growth Rating (34) in the null industry is in the same range as ORGO (39) in the Financial Conglomerates industry. This means that SHIEF’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (11) in the Financial Conglomerates industry is significantly better than the same rating for SHIEF (94) in the null industry. This means that ORGO’s stock grew significantly faster than SHIEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORGOSHIEF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
74%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
34%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
33%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 21 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 6 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLPPX9.860.09
+0.92%
LDR Real Estate Value Opportunity P
MSCQX11.840.04
+0.34%
Mercer US Small/Mid Cap Equity I
GLVAX86.610.22
+0.25%
Invesco Global Focus A
VYSGX15.660.03
+0.19%
Voya Small Company W
TICHX29.17-0.20
-0.68%
Nuveen Large Cap Responsible Eq I

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-0.60%
ANIP - ORGO
47%
Loosely correlated
-0.68%
PRGO - ORGO
46%
Loosely correlated
-2.75%
ANIK - ORGO
33%
Loosely correlated
-1.65%
AMRX - ORGO
29%
Poorly correlated
+0.73%
GTBIF - ORGO
29%
Poorly correlated
+4.55%
More

SHIEF and

Correlation & Price change

A.I.dvisor tells us that SHIEF and ORGO have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHIEF and ORGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHIEF
1D Price
Change %
SHIEF100%
N/A
ORGO - SHIEF
22%
Poorly correlated
-0.60%
VRNOF - SHIEF
14%
Poorly correlated
+5.51%
AAWH - SHIEF
11%
Poorly correlated
+6.62%
HYEX - SHIEF
3%
Poorly correlated
+7.00%
KAYS - SHIEF
2%
Poorly correlated
-2.24%
More